discharged home on antibiotics. Three days after starting the antibiotics, her face, mouth and tongue became swollen and she saw her GP who diagnosed a likely allergic reaction. She stopped the antibiotics and started antihistamines. Unfortunately the swelling then spread to involve her hands and feet. At rheumatology review she had oedema of the hands and feet. Blood pressure was low at 90/50. Her fundi were normal, her chest was clear. Blood testing from earlier that month had shown that her albumin had fallen to 29 g/l and her inflammatory markers were raised. Nephrotic syndrome was excluded. A 24 hour urine sample did not show proteinuria, chest x-ray was normal, her ECG showed sinus tachycardia. She was started on treatment doseDalteparin whilst further investigations were undertaken. She had a lower limb ultrasound and a CTPA, neither of which showed any evidence of a pulmonary embolus. An abdominal ultrasound showed some mild splenomegaly. An Echocardiogram was reported as normal. Complement levels and immunoglobulins were normal. Her swelling improved during admission. She was mobile around the ward without any breathlessness. Observations were stable, she was afebrile and was discharged home on a few days later recovered. She delivered a healthy baby girl by caesarean section in July 2015 but was admitted acutely one week later with a 24 hour history of shortness of breath, cough and chest pain. On examination on admission she had no synovitis, no rash, and no oedema. The initial differential diagnosis was felt to include pneumonia or pulmonary embolus and TB was also considered. She started appropriate treatment with antibiotics and anticoagulation. Investigation confirmed high CRP and ESR with a reduced lymphocyte count. CXR showed diffuse lung infiltrates, CTPA showed no PE but ground glass changes. ECHO showed new moderate to severe pulmonary artery hypertension (PAH). Pelvic US excluded retained products of conception. She failed to settle with antibiotics and we started treatment with first oral and then pulsed IV steroids. Despite intensive medical input over the course of the next couple of days, she continued to deteriorate and suffered a PEA arrest. Resuscitation was unsuccessful. Post mortem showed alveolar haemorrhage, a small ASD, PAH changes and fatty liver. Discussion: PAH is described in up to 10-20% of patients with Scleroderma, up to 10% in SLE but is rare in Sjö gren's. In a cohort of 107 patients with Sjö gren's a full prospective evaluation found evidence of mild to moderate PAH in 15% but no severe cases. Case reports suggest that PAH is often diagnosed late with low survival rates. There is an increased prevalence of PAH in patients with co-existent interstitial lung disease and an association with the presence of low complements, cryoglobulins and RNP antibodies. Pregnancy has an adverse effect on PAHthe increased plasma volume and decreased systemic vascular resistance with high cardiac output worsening PAH. Our patient with clinically mild Sjö gren's/lupus overlap had suffered 2 pregnancy losses followed by a successful pregnancy. In her 4th pregnancy she had an episode of SOB at 23 weeks gestation which resolved followed by the development of new PAH post-partum with catastrophic consequences. Key learning points: Consider PAH in patients presenting with CTD acuteSOBpost-partumPAHisarare, butpotentially life threatening complication of CTD's including Sjö gren's syndrome Pregnancy can worsen orprecipitate PAH Introduction: We present a patient with systemic lupus erythematosus who has had two very different experiences of pregnancy. The first was associated with poorly controlled disease and considerable morbidity for the patient and baby. The second was planned in conjunction with the combined rheumatology and obstetrics clinic and was associated with well controlled lupus and good outcomes for mother and child. Case description: Our patient, a nineteen year old lady in the twentieth week of her first pregnancy, presented with a two month history of malaise, arthralgia and myalgia, facial and orbital swelling. There was no history of previous medical problems nor of miscarriages. On examination, she had a swinging pyrexia to 38.5 degrees centigrade, facial oedema and a malar rash. There was no synovitis. There was reduced air entry at the left lung base, and oedema to the mid-thighs and sacrum. radiograph showed a left pleural effusion. She was initially treated with cefuroxime for a presumed chest infection. Further investigations showed her to be anti-nuclear antibody (ANA) positive with a homogeneous pattern, anti-Ro antibody positive, double stranded DNA antibody (dsDNA) positive at greater than 500 IU (0-60), and crithedia positive. Complement levels were low: C3 0.34 g/L (0.75-1.65) and C4 0.14 g/L (0.14-0.54). A Coombs test was positive. Anti-cardiolipin IgG antibodies were raised at 59 units (0-8), but lupus anticoagulant and anti-beta II glycoprotein 1 antibodies were negative. Twenty four hour urinary protein levels were 5.26 g (0.01-0.15). An echocardiogram showed her to have a small, posterior pericardial effusion. She was diagnosed with systemic lupus erythematosus, with haemolytic anaemia and nephrotic syndrome, and was commenced on 20mg prednisolone daily. There was an initial improvement in symptoms, but after three days she became increasingly short of breath with chest pains and palpitations. An electrocardiogram (ECG) showed atrial fibrillationat a rate of 170 beats per minute, thought to be secondary to serositis. She reverted to sinus rhythm with digoxin. A computerised tomography pulmonary angiography scan (CTPA) showed no evidence of pulmonary embolism. Prednisolone was increased to 60mg daily and aspirin 75mg daily was commenced. The patient's symptoms gradually improved and after two weeks shewas discharged on 40mg prednisolone daily.Azathioprine was started at twentyseven weeks. At twenty-eight weeks, our patient presented with headaches and blurred vision. She was found to be hypertensive and to have three pluses of blood and four pluses of protein in her urine. Atenolol was commenced. At thirty-one weeks, our patient was admitted with abdominal pain and vaginal bleeding. Haemoglobin was 85 g/L and lymphocytes 0.58x109/L. Renal and liver function were normal. Blood pressure was 133/81 mmHg. dsDNA was still strongly positive at 494 IU. C3 was 0.7 g/L and C4 0.17 g/L. Twenty four hour urinary protein was 6.89 g. She was found to have a placental abruption and went into spontaneous labour. She delivered a female baby weighing 1800 g who was looked after on the special care baby unit forher first six weeks. Shehad initial respiratory distress syndrome, jaundice and anaemia. She had a patent ductus arteriosus which subsequently resolved, bilateral subependymal haemorrhages which also resolved, and a coagulase negative staphylococcus sepsis related to her long line. The child has since made normal progress. Post-partum our patient continued to improve on azathioprine, a reducing dose of prednisolone, aspirin and atenolol. Three weeks postpartum, twenty-four hour urinary protein was 2.94 g, and by three months it was 1.04 g. Blood pressure normalised and atenolol was stopped. Prednisolone was down to 10mg daily. Six months later, there was an increase in lupus activity with fatigue, arthritis and shortness of breath. There was a neutropenia, a rise in the dsDNA and a fall in C3. There were three pluses of protein in the urine. Prednisolone was increased back to 30mg daily and azathioprine was switched to mycophenolate mofetil. Our patient improved, and for the first time since her presentation there was no evidence of protein in the urine. Two years later, our patient advised us that she was contemplating a second pregnancy.She had had good control of her lupus for twelve months. Blood pressure was 110/ 60 mmHg and there was no proteinuria. Haemoglobin was 127 g/L, lymphocytes 0.9x109/L. Renal and liver function were normal. ANA was positive (coarse speckled pattern) and anti-Ro was positive. dsDNA was 41 IU, C3 0.97 g/L and C4 0.16 g/L. She was referred to the combined rheumatology and obstetrics clinic for pre-conception counselling. She was advised to discontinue mycophenolate and to restart azathioprine. She was informed that she would have better outcomes in terms of lupus and pregnancy if her disease was stable at the time of conception. She was established on azathioprine with no deterioration in her lupus, and therefore she was encouraged to start trying for a second child. She was closely monitored in the combined clinic through her second pregnancy. At twelve weeks she developed some joint pain and swelling, and serology suggested her lupus was becoming active. Prednisolone was increased from 7.5mg to 15mg daily. She responded and stayed well through the rest of her pregnancy. She went into spontaneous labour at thirty-nineweeksand delivereda healthy female weighing3838 g. Discussion: This case is interesting because it shows the very different experiences that a woman can have during pregnancy with systemic lupus erythematosus.Withnew,poorlycontrolled diseasethere wasconsiderable morbidity for mother and child. With established and well controlled disease the pregnancy progressed smoothly. The case highlights the importance of planned and monitored pregnancies in patients with systemic lupus erythematosus, and emphasises the pivotal role that a combined rheumatology and obstetrics clinic plays in achieving this. Key learning points: SLE can present de novo in pregnancy and can be difficult to gain control of. Poorly controlled disease is associated with high maternal risk, including hypertension, pre-eclampsia and placental abruption, and high foetal risk, including prematurity. Maternal and foetal outcomes are best when lupus is quiescent prior to conception. Close POSTER CASE REPORTS 11-12 October 2017 i5 liaison between patient, rheumatologist and obstetrician is vital to help ensure aplanned and safe pregnancy.
Introduction: We present a patient with systemic lupus erythematosus who has had two very different experiences of pregnancy. The first was associated with poorly controlled disease and considerable morbidity for the patient and baby. The second was planned in conjunction with the combined rheumatology and obstetrics clinic and was associated with well controlled lupus and good outcomes for mother and child. Case description: Our patient, a nineteen year old lady in the twentieth week of her first pregnancy, presented with a two month history of malaise, arthralgia and myalgia, facial and orbital swelling. There was no history of previous medical problems nor of miscarriages. On examination, she had a swinging pyrexia to 38.5 degrees centigrade, facial oedema and a malar rash. There was no synovitis. There was reduced air entry at the left lung base, and oedema to the mid-thighs and sacrum. Initial investigations showed her to have a haemoglobin of 77 g/L (110-147), and lymphocyte count of 0.43x109/L (1-3x109/L). Renal function was normal, but liver function was deranged: alkaline phosphatase (ALP) 265 IU/L (30-130), alanine transaminase (ALT) 51 IU/L (0-33), aspartate transaminase (AST) 211 IU/L (0-32), gamma-glutamyl transpeptidase (GGT) 287 IU/L (0-40). C-reactive protein was 48 mg/L (0-5). A chest radiograph showed a left pleural effusion. She was initially treated with cefuroxime for a presumed chest infection. Further investigations showed her to be anti-nuclear antibody (ANA) positive with a homogeneous pattern, anti-Ro antibody positive, double stranded DNA antibody (dsDNA) positive at greater than 500 IU (0-60), and crithedia positive. Complement levels were low: C3 0.34 g/L (0.75-1.65) and C4 0.14 g/L (0.14-0.54). A Coombs test was positive. Anti-cardiolipin IgG antibodies were raised at 59 units (0-8), but lupus anticoagulant and anti-beta II glycoprotein 1 antibodies were negative. Twenty four hour urinary protein levels were 5.26 g (0.01-0.15). An echocardiogram showed her to have a small, posterior pericardial effusion. She was diagnosed with systemic lupus erythematosus, with haemolytic anaemia and nephrotic syndrome, and was commenced on 20mg prednisolone daily. There was an initial improvement in symptoms, but after three days she became increasingly short of breath with chest pains and palpitations. An electrocardiogram (ECG) showed atrial fibrillationat a rate of 170 beats per minute, thought to be secondary to serositis. She reverted to sinus rhythm with digoxin. A computerised tomography pulmonary angiography scan (CTPA) showed no evidence of pulmonary embolism. Prednisolone was increased to 60mg daily and aspirin 75mg daily was commenced. The patient's symptoms gradually improved and after two weeks shewas discharged on 40mg prednisolone daily.Azathioprine was started at twentyseven weeks. At twenty-eight weeks, our patient presented with headaches and blurred vision. She was found to be hypertensive and to have three pluses of blood and four pluses of protein in her urine. Atenolol was commenced. At thirty-one weeks, our patient was admitted with abdominal pain and vaginal bleeding. Haemoglobin was 85 g/L and lymphocytes 0.58x109/L. Renal and liver function were normal. Blood pressure was 133/81 mmHg. dsDNA was still strongly positive at 494 IU. C3 was 0.7 g/L and C4 0.17 g/L. Twenty four hour urinary protein was 6.89 g. She was found to have a placental abruption and went into spontaneous labour. She delivered a female baby weighing 1800 g who was looked after on the special care baby unit forher first six weeks. Shehad initial respiratory distress syndrome, jaundice and anaemia. She had a patent ductus arteriosus which subsequently resolved, bilateral subependymal haemorrhages which also resolved, and a coagulase negative staphylococcus sepsis related to her long line. The child has since made normal progress. Post-partum our patient continued to improve on azathioprine, a reducing dose of prednisolone, aspirin and atenolol. Three weeks postpartum, twenty-four hour urinary protein was 2.94 g, and by three months it was 1.04 g. Blood pressure normalised and atenolol was stopped. Prednisolone was down to 10mg daily. Six months later, there was an increase in lupus activity with fatigue, arthritis and shortness of breath. There was a neutropenia, a rise in the dsDNA and a fall in C3. There were three pluses of protein in the urine. Prednisolone was increased back to 30mg daily and azathioprine was switched to mycophenolate mofetil. Our patient improved, and for the first time since her presentation there was no evidence of protein in the urine. Two years later, our patient advised us that she was contemplating a second pregnancy.She had had good control of her lupus for twelve months. Blood pressure was 110/ 60 mmHg and there was no proteinuria. Haemoglobin was 127 g/L, lymphocytes 0.9x109/L. Renal and liver function were normal. ANA was positive (coarse speckled pattern) and anti-Ro was positive. dsDNA was 41 IU, C3 0.97 g/L and C4 0.16 g/L. She was referred to the combined rheumatology and obstetrics clinic for pre-conception counselling. She was advised to discontinue mycophenolate and to restart azathioprine. She was informed that she would have better outcomes in terms of lupus and pregnancy if her disease was stable at the time of conception. She was established on azathioprine with no deterioration in her lupus, and therefore she was encouraged to start trying for a second child. She was closely monitored in the combined clinic through her second pregnancy. At twelve weeks she developed some joint pain and swelling, and serology suggested her lupus was becoming active. Prednisolone was increased from 7.5mg to 15mg daily. She responded and stayed well through the rest of her pregnancy. She went into spontaneous labour at thirty-nineweeksand delivereda healthy female weighing3838 g. Discussion: This case is interesting because it shows the very different experiences that a woman can have during pregnancy with systemic lupus erythematosus.Withnew,poorlycontrolled diseasethere wasconsiderable morbidity for mother and child. With established and well controlled disease the pregnancy progressed smoothly. The case highlights the importance of planned and monitored pregnancies in patients with systemic lupus erythematosus, and emphasises the pivotal role that a combined rheumatology and obstetrics clinic plays in achieving this. Key learning points: SLE can present de novo in pregnancy and can be difficult to gain control of. Poorly controlled disease is associated with high maternal risk, including hypertension, pre-eclampsia and placental abruption, and high foetal risk, including prematurity. Maternal and foetal outcomes are best when lupus is quiescent prior to conception. Close liaison between patient, rheumatologist and obstetrician is vital to help ensure aplanned and safe pregnancy.
A RARE ILLNESS PRESENTING WITH COMMON SYMPTOMS AND PREGNANCY
Dr Shahzad Shikoh, James Cook University Hospital, Middlesborough Dr Muddassir Shaikh, James Cook University Hospital, Middlesborough Introduction: Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a rare, self-limiting, inflammatory eye disorder that affects the choriocapillaris, and external retinal layers with extra ocular manifestations. We report the case of a 30-year-old 11 weeks pregnant woman, who presented to Rheumatology with a history of polyarthralgia, rash on her legs and bilateral visual loss. APMPPE belongs to a group of disorders known as white dot syndromes. The exact aetiology of APMPPE is unknown. However, it is known to be associated with certain inflammatory conditions that include sarcoidosis, vasculitis, erythema nodosum and several infections. It is characterized by whitish lesions with illdefined margins, deep to the retina and concentrated in the posterior pole. It affects individuals between 20 to 30 years of age and ocular manifestations are often preceded by a flu-like illness. This condition is usually presented by sudden onset bilateral painless visual loss. Visual loss is usuallytemporary.Relapses are very rare with a good overall prognosis. Case description: 30-year-old lady pregnant patient presented with 3-4 weeks of polyarthralgia affecting joints knees, ankles, wrists, and shoulders. This was associated with joint swellings; swelling of glands in her neck and groin. She also noticed a rash around the same time on her legs, which was lumpy and tender.Initially, shewas treated with 10 days course of Phenoxymethylpenicillin with not much improvement. A week later, she started complaining of blurred vision initially in her left eye and quickly followed by the right eye She reported a history of shivering, sweating and feeling hot at the onset of symptoms, however no specific infection history. There was no history of any a sore throat. There were no other significant symptoms on systemic enquiry. There was no personal history of autoimmune diseases. There was no history of DVT/PE or recurrent miscarriages. There were no other symptoms suggesting connective tissue disease. Her uncle has psoriasis. She has three healthy children and her youngest one is 4 1 =2 months old. On examination were no vasculitic rashes. There was any synovitis in her joints. She has multiple lumps on both legs which were slightly bluish/purplish and slightly tender which may represent erythema nodosum. There was no lymphadenopathy. Her chest was clear and heart sounds were normal. Blood pressure was normal and urine dipstick was clear. The blood test showed ESR was 26 and CRP was 50. FBC, U and E's, LFT's, Coagulation screen, CK, Ferritin, Serum ACE, BNP and Corrected Calcium were all normal. ASO titers were slightly raised 270. Hepatitis B, C, HIV and Syphilis screen were negative. Autoimmune screen including HLA B27, ANA, rheumatoid factor and anti-CCP antibodies were negative; immunoglobulins and serum electrophoresis were normal. ANCA, ENA, Antiphosphospholipid screen was awaited. She was reviewed in the Ophthalmology clinic urgently. Visual acuity was significantly reduced in both eyes. Ophthalmological findings revealed characteristic multiple yellow-white sub-retinal lesions in the posterior pole of both eyes probably consistent with APMPPE. She was started on Prednisolone 60mg by Opthalmology. Oral steroids settled her visual symptoms within few days. The rash improved and so was the joint swellings. The lumps in her groin and neck disappeared as well. Repeat blood within 4 days of starting steroids, showed and ESR down to 15 and CRP of less than 5. She had a transthoracic echocardiography done which showed no evidence of carditis, a normal LV/RV size and function and mild-moderate pulmonary regurgitation. Discussion:Thispatient presented with multiple symptoms:polyarthralgia, a rash that could represent erythema nodosum, acute bilateral visual loss, and raised inflammatory markers. The differential diagnosis is broad which included sarcoidosis, seronegative arthropathy, rheumatic fever, vasculitis and atypical infections. This case is further complicated by the fact that the patient is pregnant which can have potential implications for diagnosis and treatment. When arranging investigations, such as imaging,onehastoweighrisksversusbenefits.Earlyinvolvementof otherspecialities, in particular, Obstetrics and Ophthalmology, is crucial. In this case, the Ophthalmologists clinched the diagnosis based on their findings. APMPPE is not commonly seen in routine rheumatology practice. While common things are common, rare conditions like APMPPE does exist and it is useful to keep them in mind and to be able to recognize their potential link to other autoimmune conditions like sarcoidosis and vasculitis when assessing patients with unexplained multiple symptoms associated with raised inflammatory markers. Early and close collaboration with other specialities is imperative.We would be interested to know experts panel thoughts on their approach when assessing such patients, presenting with unexplained multiple systemic features associated with objective abnormalities on investigations like raised inflammatory markers; their strategies to rule out rare conditions and to be able to come to the diagnosis especially in these challenging scenarios. Key learning points: Main learning points for me and my colleagues are seeking prompt and close collaboration with all the other relevant specialties when assessing a patient presenting with unexplained systemic illness; where there is diagnostic uncertainty. Besides, as per this case, the combination of inflammatory eye conditions and systemic symptoms should prompt a general work up to exclude autoimmune conditions such as sarcoidosis. A delayed diagnosis such as cardiac sarcoidosis may have life-threatening consequences and the ophthalmologist may be the first specialty to pick up these rare conditions as was in this case. Introduction: We report the outcome of an atypical haemolytic uraemic syndrome (aHUS) in a 30 year old British-Asian prima-gravida with Lupus/Sjogren's Syndrome overlap. A combination of therapies including plasma exchange, methylprednisolone pulses and compassionate use of Eculizumab, a c5 inhibiting monoclonal antibody, was lifesaving. The appearance of a microangiopathic haemolytic anaemia (MAHA) and thrombocytopaenia in pregnancy is challenging. The causes can include sepsis, placental abnormalities, anti-phospholipid syndrome, and thrombotic microangiopathies (TMA) including pre-eclampsia/HELLP (haemolysis, elevated liver enzymes, low platelets) syndromes, thrombotic thrombocytopaenic purpura (TTP) and a spectrum of complement mediated conditions thrombotic microangiopathies (also known as atypical haemolytic uraemic syndrome, aHUS). The timings of these complications can vary, presenting anywhere from first trimester to the postpartum period. In a pregnant woman who also has lupus, these presentationscanmimicalupusflare,they areassociated withsignificantmaternal and foetal mortality; even with survival there can be life-changing sequelae. Eculizumab is a recombinant humanized monoclonal antibody which acts as aterminal inhibitorof the complementcascadeand was approved for use in aHUS in the UK in 2015: use in lupus is rare and illustrates important learning points. Case description: A 30 year old British-Asian woman had a diagnosis of with lupus/Sjogren's syndrome overlap and non-progressive interstitial lung disease. Her autoantibody profile included positivity for anti-Ro and anti-Laantibodiesandforrheumatoidfactor. ComplementC3andC4lev-els and quantitative double stranded DNA remained in physiological range and she had persistent low level haematuria and proteinuria with preserved renal function. She was maintained on 200 mg of hydroxychloroquine and up to 20 mg of prednisolone daily, having failed a trial of methotrexate. Other disease modifying anti-rheumatic drugs such as azathioprine were considered but this choice was complicated by low thiopurine methyltransferase level, and the patient declined. She had one episode of post-anti-streptolysin O positive arthralgia and renal impairment which settled with an increased steroid course. Three years after initial diagnosis she was able to conceive naturally. In early pregnancy, her condition was reported as stable, and she was referred to a combined rheumatology/obstetrics clinic. In the nineteenth week of pregnancy, she presented to the emergency department with multi organ involvement including acute confusion, multiple epileptic seizures, acute renal and cardiac insufficiency, and absence of foetal heartbeat. Haematology investigations showed thrombocytopaenia, reduced haptoglobins, and the presence of schistocytes on blood film in keeping with a microangiopathic haemolytic anaemia (MAHA). There was nephrotic range proteinuria (2300 mg/mmol) and creatinine had doubled from previous baseline to 109 micromol/L. Her condition became critical and she was transferred with life threatening thrombotic microangiopathy to the local tertiary centre for access to plasma exchange. She required intensive care admission with invasive ventilator support and a tracheostomy. Magnetic Resonance Imaging of her brain was consistent with posterior reversible encephalopathy syndrome (PRES). An echocardiogram showed moderate left ventricular systolic dysfunction with regional wall motion abnormalities. At nineteen gestational weeks, the presence of MAHA, thrombocytopaenia and acute renal injury was compatible with several possible overlapping diagnoses. This included sepsis with disseminated intravascular coagulation (DIC), anti-phospholipid syndrome, i6 11-12 October 2017 POSTER CASE REPORTS
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